When is a double beat and raise not enough to prevent a double-digit drawdown? When you drop a surprise business transaction on the market with little information or concrete figures. That’s exactly what happened when CVS Health Corp. (NYSE: CVS) reported its third-quarter results on Nov. 4.
Management announced it would split the health services and pharmacy businesses but did not provide specifics on costs or balance sheet allocation. Markets hate uncertainty, and unfortunately CVS clouded a strong Q3 report with vague details on a major announcement. Can management provide enough color to satisfy shareholders?